99 related articles for article (PubMed ID: 3551695)
1. Effect of oral treatment with pantethine on platelet and plasma phospholipids in IIa hyperlipoproteinemia.
Prisco D; Rogasi PG; Matucci M; Paniccia R; Abbate R; Gensini GF; Neri Serneri GG
Angiology; 1987 Mar; 38(3):241-7. PubMed ID: 3551695
[TBL] [Abstract][Full Text] [Related]
2. Changes in fatty acid composition of the single platelet phospholipids induced by pantethine treatment.
Gensini GF; Prisco D; Rogasi PG; Matucci M; Neri Serneri GG
Int J Clin Pharmacol Res; 1985; 5(5):309-18. PubMed ID: 4066081
[TBL] [Abstract][Full Text] [Related]
3. Pantethine versus fenofibrate in the treatment of type II hyperlipoproteinemia.
Postiglione A; Rubba P; Cicerano U; Chierchia I; Mancini M
Monogr Atheroscler; 1985; 13():145-8. PubMed ID: 3911056
[No Abstract] [Full Text] [Related]
4. Influence of pantethine on platelet volume, microviscosity, lipid composition and functions in diabetes mellitus with hyperlipidemia.
Hiramatsu K; Nozaki H; Arimori S
Tokai J Exp Clin Med; 1981 Jan; 6(1):49-57. PubMed ID: 7256794
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein changes induced by pantethine in hyperlipoproteinemic patients: adults and children.
Bertolini S; Donati C; Elicio N; Daga A; Cuzzolaro S; Marcenaro A; Saturnino M; Balestreri R
Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):630-7. PubMed ID: 3098691
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of long-term treatment with pantethine in patients with dyslipidemia.
Arsenio L; Bodria P; Magnati G; Strata A; Trovato R
Clin Ther; 1986; 8(5):537-45. PubMed ID: 3094958
[TBL] [Abstract][Full Text] [Related]
7. Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients.
Véricel E; Colas R; Calzada C; Lê QH; Feugier N; Cugnet C; Vidal H; Laville M; Moulin P; Lagarde M
Thromb Haemost; 2015 Aug; 114(2):289-96. PubMed ID: 25832443
[TBL] [Abstract][Full Text] [Related]
8. [Effects of 4 weeks' intake of polyunsaturated fatty acid ethylester rich in eicosapentaenoic acid (ethylester) on plasma lipids, plasma and platelet phospholipid fatty acid composition and platelet aggregation; a double blind study].
Kawamura M; Naito C; Hayashi H; Hashimoto Y; Kato H; Matsushima T
Nihon Naika Gakkai Zasshi; 1983 Jan; 72(1):18-24. PubMed ID: 6343532
[No Abstract] [Full Text] [Related]
9. Influence of a hypolipemic drug (procetofene) on platelet functions and lipid composition in type II B hyperlipoproteinemia.
Renaud S; Morazain R; Sauvanet JP; Dumont E; Drouin P
Haemostasis; 1979; 8(2):82-95. PubMed ID: 499929
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients.
Hochgraf E; Levy Y; Aviram M; Brook JG; Cogan U
Metabolism; 1994 Jan; 43(1):11-7. PubMed ID: 8289667
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol (PI) and PI-associated arachidonate are elevated in platelet total membranes of type IIa hypercholesterolemic subjects.
Mosconi C; Colli S; Tremoli E; Galli C
Atherosclerosis; 1988 Aug; 72(2-3):129-34. PubMed ID: 3214465
[TBL] [Abstract][Full Text] [Related]
12. The depletion of plasma prolactin by pantethine in oestrogen-primed hyperprolactinaemic rats.
Jeitner TM; Oliver JR
J Endocrinol; 1990 Mar; 124(3):397-402. PubMed ID: 2332716
[TBL] [Abstract][Full Text] [Related]
13. Altered phospholipid composition of plasma membranes from thrombin-stimulated human platelets.
Skeaff CM; Holub BJ
Biochim Biophys Acta; 1985 Apr; 834(2):164-71. PubMed ID: 3995060
[TBL] [Abstract][Full Text] [Related]
14. [A double-blind clinical trial--the effects of pantethine on serum lipids in patients with hyperlipidemia].
Lu ZL
Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Aug; 17(4):221-3. PubMed ID: 2697544
[No Abstract] [Full Text] [Related]
15. [Clinical use of pantethine by parenteral route in the treatment of hyperlipidemia].
Arsenio L; Bodria P; Bossi S; Lateana M; Strata A
Acta Biomed Ateneo Parmense; 1987; 58(5-6):143-52. PubMed ID: 2970754
[TBL] [Abstract][Full Text] [Related]
16. Composition of platelet phospholipids after moderate consumption of red wine in healthy volunteers.
Pellegrini N; Simonetti P; Brusamolino A; Bottasso B; Pareti FI
Eur J Clin Nutr; 1996 Aug; 50(8):535-44. PubMed ID: 8863014
[TBL] [Abstract][Full Text] [Related]
17. Influence of some plasma fatty acids on the phospholipid fatty acid pattern of human platelets--an "ex vivo" experience.
Vallés J; Aznar J; Santos MT
Thromb Haemost; 1984 Dec; 52(3):232-5. PubMed ID: 6531750
[TBL] [Abstract][Full Text] [Related]
18. [Changes in the fatty acid composition of erythrocyte and platelet membranes after diet therapy in patients with hyperlipoproteinemia type II].
Korf II; Meshcheriakova VA; Samsonov MA; Chepurnenko NV; Koshechkin VA
Vopr Med Khim; 1987; 33(3):73-7. PubMed ID: 3630021
[TBL] [Abstract][Full Text] [Related]
19. Decreased erythrocyte and platelet phospholipids and fatty acids in juvenile neuronal ceroid-lipofuscinosis (Batten disease).
Bennett MJ; Galloway JH; Cartwright IJ; Gillis WS; Hosking GP
Neuropediatrics; 1990 Nov; 21(4):202-5. PubMed ID: 2290481
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of chronic hepatopathies with phosphorylcholine and pantethine].
Proietti C; Imperiale A; Chiti D
Clin Ter; 1984 Aug; 110(3):251-7. PubMed ID: 6237863
[No Abstract] [Full Text] [Related]
[Next] [New Search]
